These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1985611)

  • 1. Decreased mortality in users of estrogen replacement therapy.
    Henderson BE; Paganini-Hill A; Ross RK
    Arch Intern Med; 1991 Jan; 151(1):75-8. PubMed ID: 1985611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen replacement therapy in the elderly.
    Paganini-Hill A
    Zentralbl Gynakol; 1996; 118(5):255-61. PubMed ID: 8701621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmenopausal hormone therapy and mortality.
    Grodstein F; Stampfer MJ; Colditz GA; Willett WC; Manson JE; Joffe M; Rosner B; Fuchs C; Hankinson SE; Hunter DJ; Hennekens CH; Speizer FE
    N Engl J Med; 1997 Jun; 336(25):1769-75. PubMed ID: 9187066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noncontraceptive estrogens and mortality: long-term follow-up of women in the Walnut Creek Study.
    Petitti DB; Perlman JA; Sidney S
    Obstet Gynecol; 1987 Sep; 70(3 Pt 1):289-93. PubMed ID: 3627576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen replacement therapy and risk of Alzheimer disease.
    Paganini-Hill A; Henderson VW
    Arch Intern Med; 1996 Oct; 156(19):2213-7. PubMed ID: 8885820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen replacement therapy and mortality among older women. The study of osteoporotic fractures.
    Cauley JA; Seeley DG; Browner WS; Ensrud K; Kuller LH; Lipschutz RC; Hulley SB
    Arch Intern Med; 1997 Oct; 157(19):2181-7. PubMed ID: 9342994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasomotor symptoms and mortality: the Rancho Bernardo Study.
    Svartberg J; von Mühlen D; Kritz-Silverstein D; Barrett-Connor E
    Menopause; 2009; 16(5):888-91. PubMed ID: 19421076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risks and benefits of estrogen replacement therapy: Leisure World.
    Paganini-Hill A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 1():54-62. PubMed ID: 7581589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women.
    Tamimi RM; Hankinson SE; Chen WY; Rosner B; Colditz GA
    Arch Intern Med; 2006 Jul; 166(14):1483-9. PubMed ID: 16864758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of dementia in long-term hormone users.
    Petitti DB; Crooks VC; Chiu V; Buckwalter JG; Chui HC
    Am J Epidemiol; 2008 Mar; 167(6):692-700. PubMed ID: 18218608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
    Grodstein F; Manson JE; Stampfer MJ
    J Womens Health (Larchmt); 2006; 15(1):35-44. PubMed ID: 16417416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long-term impact of 2-3 years of hormone replacement therapy on cardiovascular mortality and atherosclerosis in healthy women.
    Alexandersen P; Tankó LB; Bagger YZ; Qin G; Christiansen C
    Climacteric; 2006 Apr; 9(2):108-18. PubMed ID: 16698657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of evidence for effect modification by estrogen of association between body mass index and colorectal cancer risk among postmenopausal women.
    Wang Y; Jacobs EJ; Teras LR; Pavluck AL; Rodriguez C; Thun MJ; Calle EE
    Cancer Causes Control; 2007 Oct; 18(8):793-9. PubMed ID: 17619155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The benefits of estrogen replacement therapy on oral health. The Leisure World cohort.
    Paganini-Hill A
    Arch Intern Med; 1995 Nov; 155(21):2325-9. PubMed ID: 7487257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased incidence of breast cancer in postmenopausal estrogen-progestogen users.
    Gambrell RD; Maier RC; Sanders BI
    Obstet Gynecol; 1983 Oct; 62(4):435-43. PubMed ID: 6888821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menopausal estrogen therapy predicts better nocturnal oxyhemoglobin saturation.
    Saaresranta T; Polo-Kantola P; Virtanen I; Vahlberg T; Irjala K; Polo O
    Maturitas; 2006 Oct; 55(3):255-63. PubMed ID: 16675167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vascular disease and hormonal treatment--epidemiology].
    Vessey MP
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):121-6. PubMed ID: 12280197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.